Status:

RECRUITING

The METRIC Study Protocol

Lead Sponsor:

Université du Québec à Trois-Rivières

Conditions:

Chronic Low-back Pain

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to test the effects of spinal manipulative therapy in individuals with chronic primary low back pain and determine the neurophysiological mechanisms underlying pain ...

Eligibility Criteria

Inclusion

  • Duration of current low back pain (LBP) episode ≥ 6 months;
  • Average LBP intensity during the last 7 days ≥ 3/10;
  • (For healthy volunteers only) To be of the same sex and age (± 1 year) as a participant with low back pain.

Exclusion

  • Diagnosis of back conditions other than chronic primary LBP e.g., failed back surgery syndrome, spondylosis, spondylolisthesis, spinal stenosis, herniated disc, infection, etc.;
  • Presence of pain in another body location that is more severe than the pain in the lower back;
  • Presence of a neurological deficit i.e., sensation loss, muscle weakness, decreased deep tendon reflexes;
  • Presence of contraindications to spinal manipulative therapy e.g., recent fracture, history of spinal surgery, cauda equina syndrome, inflammatory arthritis, taking anticoagulant medication, active cancer, moderate to severe osteoporosis, abdominal aortic aneurysm;
  • Underwent surgery in the last 3 months;
  • Pregnancy, ≤ 3 months post-partum or planning to get pregnant in the next 12 months;
  • History of spinal manipulative therapy in the past 12 months;
  • Scoliosis ≥ 20°;
  • BMI ≥ 40;
  • Insufficient language skills in French to complete the questionnaires;
  • Open or pending litigation for LBP or seeking/receiving disability compensation;
  • Diagnosis of an illness affecting the sensorimotor functions e.g., diabetes, multiple sclerosis, amyotrophic lateral sclerosis;
  • Diagnosis of mental health disorders (with the exception of anxiety and depression);
  • Current drug or alcohol dependence;
  • Skin of type I on the Fitzpatrick scale;
  • (For healthy volunteers only) Regular use of pain medication or usage in the 48 h prior to data collection;
  • (For healthy volunteers only) History of chronic pain;
  • (For healthy volunteers only) Acute pain on the days of data collection.

Key Trial Info

Start Date :

October 25 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

112 Patients enrolled

Trial Details

Trial ID

NCT05986370

Start Date

October 25 2023

End Date

December 31 2026

Last Update

December 4 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Université du Québec à Trois-Rivières

Trois-Rivières, Quebec, Canada, G8Z 4M3